Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Developing new drugs for diabetes and cardiometabolic disorders: a changing paradigm.

× No keyword cloud information.

10 in total

1. Lessons from Lipitor and the broken blockbuster drug model.

Authors:
Journal: Lancet Date: 2011-12-10 Impact factor: 79.321

2. Approval of biosimilars in the USA--dead ringers?

Authors:
Journal: Lancet Date: 2012-02-25 Impact factor: 79.321

Review 3. Anti-obesity drugs: a review about their effects and their safety.

Authors: Giuseppe Derosa; Pamela Maffioli
Journal: Expert Opin Drug Saf Date: 2012-03-23 Impact factor: 4.250

Review 4. Recent advances in the pathophysiology and pharmacological treatment of obesity.

Authors: P K Chugh; S Sharma
Journal: J Clin Pharm Ther Date: 2012-03-30 Impact factor: 2.512

5. Is glycemic control improving in U.S. adults?

Authors: Thomas J Hoerger; Joel E Segel; Edward W Gregg; Jinan B Saaddine
Journal: Diabetes Care Date: 2007-10-12 Impact factor: 19.112

6. Rosiglitazone: trials, tribulations and termination.

Authors: Andrew J Krentz
Journal: Drugs Date: 2011-01-22 Impact factor: 9.546

7. Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study.

Authors: Patrick M O'Neil; Steven R Smith; Neil J Weissman; Meredith C Fidler; Matilde Sanchez; Jinkun Zhang; Brian Raether; Christen M Anderson; William R Shanahan
Journal: Obesity (Silver Spring) Date: 2012-03-16 Impact factor: 5.002

Review 8. Evolving treatment strategies for the management of type 2 diabetes.

Authors: William T Cefalu
Journal: Am J Med Sci Date: 2012-01 Impact factor: 2.378

Review 9. GLP-1 receptor agonists: a clinical perspective on cardiovascular effects.

Authors: Dhanwantee Mundil; Alison Cameron-Vendrig; Mansoor Husain
Journal: Diab Vasc Dis Res Date: 2012-04 Impact factor: 3.291

10. Dapagliflozin: an evidence-based review of its potential in the treatment of type-2 diabetes.

Authors: Edward C Chao
Journal: Core Evid Date: 2012-06-01

10 in total